glp 1 parkinson's disease Are we measuring the wrong primary outcome for GLP-1 drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep GLP-1/GIP dual agonist tirzepatide alleviates

Your time is valuable, and each session is designed to fit seamlessly into your busy schedule while providing maximum results

Three treatments, spaced one month apart, with this laser will treat sun damage and diffuse pigmentation and leave the skin beautiful and even

Crafted with durable, high-quality ingredients, this serum is formulated to absorb quickly and provide long-lasting hydration

Because that description could easily match insulin, but its also a perfect match for another hormone: GLP-1

The more relevant research question is whether triple receptor agonism (GIP + GLP-1 + glucagon) combining elements of both approaches could outperform either dual agonist